Company Information
Basilea Pharmaceutica AG
Grenzacherstrasse 487
4058 Basel
Switzerland
+41 61 606 1233
http://www.basileapharma.com
- CEO
- Anthony Man
- Investor Relations
- Sean Wells
Basilea Pharmaceutica AG founded in 2000 is an independent biopharmaceutical company headquartered in Basel, Switzerland that is engaged in the discovery and development of medicines for the treatment of unmet medical needs. The company's fully integrated research and development operations are currently focused on new anti-bacterial agents, anti-fungal agents and dermatology drugs.
Trading Information
- Sector
- Health Care - 4500
- Regulatory Standard
- International Reporting Standard
- Security Number
- 1143244
- ISIN
- CH0011432447
- Symbol
- BSLN
- Index member
- SPI
Intermediaries
- Listing Agent
- Credit Suisse First Boston
- Lead Bank
- Credit Suisse First Boston & Morgan Stanley
- Auditor
- PricewaterhouseCoopers AG
Information on the Issue
| Security Details | |
|---|---|
| First Listing | 25.03.2004 |
| Class of Share | Registered Share |
| Nominal Value | 1.00 CHF |
| Total Shares outstanding (post issue; incl. Greenshore - if any) | 7695141 |
| Allocation Details | |
|---|---|
| Primary Shares | 2100000 |
| Secondary Shares | n/a |
| Primary Greenshoe | n/a |
| Secondary Greenshoe | n/a |
| Greenshoe Details | |
|---|---|
| Executed | no GS at all |
| Ex-date | n/a |
| Executed number of shares | n/a |
| First Trading Day Details | |
|---|---|
| First Trading | 25.03.2004 |
| Price Range | 90.00 - 115.00 CHF |
| Issue Price | 98.00 CHF |
| First Open | 113.00 CHF |
| First Close | 101.00 CHF |
| Transaction size in Mio. (incl. executed Greenshoe) | 205.8 CHF |
| Market Capitalisation in Mio. (based on first closing price) | 777 CHF |
Financial Statement
| Number of Employees | 175 2003 |
| Net Revenues in Mio. | 0.4 CHF 2003 |
| Net Gain in Mio. | n/a |